NOD2 and bronchiolitis obliterans syndrome: This study aims to demonstrate that multivariate analysis proved recipient but not donor NOD2/CARD15 variants to be a novel independent risk factor for BO development, and NOD2/CARD15 typing may help identify patients at increased risk for bronchiolitis obliterans complications.